Cargando…
Antiarrhythmic effects of ginsenoside Rg2 on calcium chloride–induced arrhythmias without oral toxicity
BACKGROUND: Malignant arrhythmias require drug therapy. However, most of the currently available antiarrhythmic drugs have significant side effects. Ginsenoside Rg2 exhibits excellent cardioprotective effects and appears to be a promising candidate for cardiovascular drug development. So far, the or...
Autores principales: | Gou, Dongxia, Pei, Xuejing, Wang, Jiao, Wang, Yue, Hu, Chenxing, Song, Chengcheng, Cui, Sisi, Zhou, Yifa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471212/ https://www.ncbi.nlm.nih.gov/pubmed/32913401 http://dx.doi.org/10.1016/j.jgr.2019.06.005 |
Ejemplares similares
-
Acute and repeated dose 26-week oral toxicity study of 20(S)-ginsenoside Rg3 in Kunming mice and Sprague–Dawley rats
por: Li, Chunmei, et al.
Publicado: (2020) -
Cardiac Arrhythmias and Antiarrhythmic Drugs: An Autophagic Perspective
por: van Bavel, Joanne J. A., et al.
Publicado: (2018) -
Ginsenoside Rg5 overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter: in vitro and in vivo study
por: Feng, Sen-Ling, et al.
Publicado: (2020) -
Relationship Between Ginsenoside Rg3 and Metabolic Syndrome
por: Lee, Hyunji, et al.
Publicado: (2020) -
Proteomic analyses reveal that ginsenoside Rg3(S) partially reverses cellular senescence in human dermal fibroblasts by inducing peroxiredoxin
por: Jang, Ik-Soon, et al.
Publicado: (2020)